TAJ-β inhibitors represent a specialized class of chemical compounds designed to specifically inhibit the function of the TAJ-β protein, a molecule known to play a role in various cellular regulatory pathways. TAJ-β inhibitors operate by binding to the active sites or key functional domains of the TAJ-β protein, thus preventing its normal activity within the cell. These inhibitors are often developed to fit the precise structural features of the TAJ-β protein, ensuring that they can effectively block its interactions or catalytic actions. The inhibitors may target different regions of the protein, such as its binding pockets or allosteric sites, depending on their mode of action and the specific mechanism by which they interfere with the protein's function. The chemical design of TAJ-β inhibitors is crucial for achieving a high degree of specificity, ensuring they interact with TAJ-β while minimizing interaction with other proteins.
TAJ-β inhibitors are synthesized using advanced organic synthesis techniques that allow the precise assembly of molecules with defined structural features. These compounds often feature a combination of hydrophobic and hydrophilic regions that are designed to complement the three-dimensional shape of the TAJ-β protein. Some inhibitors may include functional groups capable of forming strong covalent or non-covalent bonds with the protein's active sites, thereby enhancing their inhibitory potency. The solubility, stability, and reactivity of these inhibitors are carefully considered during their design, as these properties influence how effectively the inhibitor can interact with TAJ-β under different conditions. The diversity in the structural composition of TAJ-β inhibitors allows for the fine-tuning of their binding affinities, making them a valuable class of compounds for studying the biochemical functions and regulatory mechanisms associated with the TAJ-β protein.
Items 1 to 10 of 11 total
Mostrar:
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | ¥338.00 ¥1410.00 ¥5020.00 | 45 | |
Inhibe la p38 MAPK, afectando potencialmente a las vías de respuesta inflamatoria en las que podría estar implicada la TAJ-β. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | ¥1365.00 ¥4423.00 | 148 | |
inhibidor de la PI3K, podría alterar vías de señalización importantes para la supervivencia y la proliferación celular. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | ¥301.00 ¥1128.00 | 257 | |
inhibidor de JNK, podría influir en las vías de respuesta al estrés y la apoptosis relacionadas con la actividad de TAJ-β. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | ¥711.00 ¥2719.00 | 136 | |
inhibidor de MEK, afectando potencialmente a la vía MAPK/ERK, lo que podría ser relevante para la función de TAJ-β. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | ¥745.00 ¥2471.00 ¥4705.00 | 97 | |
Otro inhibidor de PI3K, podría afectar aún más a las vías de señalización en las que se cree que participa TAJ-β. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | ¥699.00 ¥1749.00 ¥3610.00 | 233 | |
inhibidor de mTOR, podría modular el crecimiento celular y los procesos de autofagia asociados a TAJ-β. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | ¥632.00 ¥2933.00 ¥4693.00 | 129 | |
inhibidor de la quinasa RAF, podría afectar a las vías de crecimiento y diferenciación celular en las que interviene TAJ-β. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | ¥835.00 | 256 | |
Inhibidor pan-caspasa, potencialmente influyente en las vías de apoptosis que TAJ-β podría regular. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | ¥1489.00 ¥12004.00 | 115 | |
inhibidor del proteasoma, podría afectar a las vías de degradación de proteínas relevantes para la función de TAJ-β. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | ¥1230.00 ¥3949.00 | 8 | |
Modula el NF-κB y otras moléculas de señalización, afectando potencialmente a la inflamación y al crecimiento celular. | ||||||